BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hamo CE, Gheorghiade M, Butler J. Novel Endpoints for Heart Failure Clinical Trials. Curr Heart Fail Rep 2017;14:210-6. [DOI: 10.1007/s11897-017-0334-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Zile MR, Abraham WT, Lindenfeld J, Weaver FA, Zannad F, Graves T, Rogers T, Galle EG. First granted example of novel FDA trial design under Expedited Access Pathway for premarket approval: BeAT-HF. American Heart Journal 2018;204:139-50. [DOI: 10.1016/j.ahj.2018.07.011] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
2 Banerjee MN, Bolli R, Hare JM. Clinical Studies of Cell Therapy in Cardiovascular Medicine: Recent Developments and Future Directions. Circ Res 2018;123:266-87. [PMID: 29976692 DOI: 10.1161/CIRCRESAHA.118.311217] [Cited by in Crossref: 71] [Cited by in F6Publishing: 43] [Article Influence: 23.7] [Reference Citation Analysis]
3 Khan MS, Siddiqi TJ, Butler J, Friede T, Levy WC, Witte KK, Lipiecki J, Sievert H, Coats AJS. Functional outcomes with Carillon device over 1 year in patients with functional mitral regurgitation of Grades 2+ to 4+: results from the REDUCE-FMR trial. ESC Heart Fail 2021;8:872-8. [PMID: 33619896 DOI: 10.1002/ehf2.13273] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Parikh KS, Sharma K, Fiuzat M, Surks HK, George JT, Honarpour N, Depre C, Desvigne-nickens P, Nkulikiyinka R, Lewis GD, Gomberg-maitland M, O’connor CM, Stockbridge N, Califf RM, Konstam MA, Januzzi JL, Solomon SD, Borlaug BA, Shah SJ, Redfield MM, Felker GM. Heart Failure With Preserved Ejection Fraction Expert Panel Report. JACC: Heart Failure 2018;6:619-32. [DOI: 10.1016/j.jchf.2018.06.008] [Cited by in Crossref: 59] [Cited by in F6Publishing: 56] [Article Influence: 14.8] [Reference Citation Analysis]
5 Martinelli AEM, Maranhão RC, Carvalho PO, Freitas FR, Silva BMO, Curiati MNC, Kalil Filho R, Pereira-Barretto AC. Cholesteryl ester transfer protein (CETP), HDL capacity of receiving cholesterol and status of inflammatory cytokines in patients with severe heart failure. Lipids Health Dis 2018;17:242. [PMID: 30342531 DOI: 10.1186/s12944-018-0888-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
6 Chang AM, Pang PS, Butler J, Storrow AB, Levy PD, Lindenfeld J, Collins SP. Early Treatment in Emergency Department Patients with Acute Heart Failure: Does Time Matter? Curr Heart Fail Rep 2019;16:12-20. [PMID: 30828762 DOI: 10.1007/s11897-019-0419-y] [Reference Citation Analysis]